Akira Imamoto

Affiliations: 
University of Chicago, Chicago, IL 
Area:
Cell Biology, Molecular Biology
Google:
"Akira Imamoto"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Imamoto A, Ki S, Li L, et al. (2020) Essential role of the family-dosage in DiGeorge-like anomaly and metabolic homeostasis. Life Science Alliance. 3
Haller M, Mo Q, Imamoto A, et al. (2017) Murine model indicates 22q11.2 signaling adaptor CRKL is a dosage-sensitive regulator of genitourinary development. Proceedings of the National Academy of Sciences of the United States of America
Shigeno-Nakazawa Y, Kasai T, Ki S, et al. (2016) A pre-metazoan origin of the CRK gene family and co-opted signaling network. Scientific Reports. 6: 34349
Zeng L, Ehrenreiter K, Menon J, et al. (2013) RKIP regulates MAP kinase signaling in cells with defective B-Raf activity. Cellular Signalling. 25: 1156-65
Yamagishi J, Okimoto N, Kasai T, et al. (2013) 1P043 Computational design of short peptide inhibitors of protein-protein interactions in intracellular signaling mediated by CRK-SH2(01B. Protein:Structure & Function,Poster) Seibutsu Butsuri. 53
Seo JH, Wood LJ, Agarwal A, et al. (2010) A specific need for CRKL in p210BCR-ABL-induced transformation of mouse hematopoietic progenitors. Cancer Research. 70: 7325-35
Shemon AN, Eves EM, Clark MC, et al. (2009) Raf Kinase Inhibitory Protein protects cells against locostatin-mediated inhibition of migration. Plos One. 4: e6028
Seo JH, Suenaga A, Hatakeyama M, et al. (2009) Structural and functional basis of a role for CRKL in a fibroblast growth factor 8-induced feed-forward loop. Molecular and Cellular Biology. 29: 3076-87
Zeng L, Imamoto A, Rosner MR. (2008) Raf kinase inhibitory protein (RKIP): a physiological regulator and future therapeutic target. Expert Opinion On Therapeutic Targets. 12: 1275-87
Zhu F, Choi BY, Ma WY, et al. (2006) COOH-terminal Src kinase-mediated c-Jun phosphorylation promotes c-Jun degradation and inhibits cell transformation. Cancer Research. 66: 5729-36
See more...